TARDBP and amyotrophic lateral sclerosis: PrLDs can mediate pathologically aggregated states observed in the ALS/FTD brain as a result of aging, and/or ALS-linked mutations clustered in the PrLDs of TDP-43 and FUS and which accelerate this toxic conversion to initiate neurodegeneration.